Andere Kunden interessierten sich auch für
![Interleukin 28-B polymorphism associated with HCV treatment]( "Interleukin 28-B polymorphism associated with HCV treatment")
Interleukin 28-B polymorphism associated with HCV treatment46,99 €![Role of Rosiglitazone & Felodipine in attenuation of cardiac fibrosis]( "Role of Rosiglitazone & Felodipine in attenuation of cardiac fibrosis")
Role of Rosiglitazone & Felodipine in attenuation of cardiac fibrosis36,99 €![Key role of galectins in corneal hem-, lymph-angiogenesis and fibrosis]( "Key role of galectins in corneal hem-, lymph-angiogenesis and fibrosis")
Key role of galectins in corneal hem-, lymph-angiogenesis and fibrosis19,99 €![The Cystic Fibrosis Transmembrane Conductance Regulator]( "The Cystic Fibrosis Transmembrane Conductance Regulator")
The Cystic Fibrosis Transmembrane Conductance Regulator125,99 €![Plasma free amino acids changes in HCC patients]( "Plasma free amino acids changes in HCC patients")
Plasma free amino acids changes in HCC patients36,99 €![Thyroid Dysfunction Associated with Dyslipidemias and major organs]( "Thyroid Dysfunction Associated with Dyslipidemias and major organs")
Thyroid Dysfunction Associated with Dyslipidemias and major organs51,99 €![LMP 7 gene and response to IFN-therapy in HCV infected patients]( "LMP 7 gene and response to IFN-therapy in HCV infected patients")
LMP 7 gene and response to IFN-therapy in HCV infected patients40,99 €
Hepatocellular carcinoma (HCC) is a sophisticated health challenge; it represents the second leading cause of cancer-related mortality, where HCC is more prevalent in chronic hepatitis C virus (HCV) infected patients. Hepatic carcinogenesis is a slowly progressive, poorly understood multistep process, and there is a close association between chronic hepatitis C infection, liver cirrhosis and the development of HCC. Alteration in hepatic microenvironment mediates the carcinogenesis and carries the clues for better treatment strategies. HCV can significantly disturb the cellular redox status, which provokes alteration in the liver microenvironment and activation of the hepatic stellate cell which is the key in liver fibrogenesis. This book, therefore, aimed to assess the oxidative status biomarkers, in addition to fibrotic markers including microfibrillar-associated protein 4 (MFAP4) and fibrotic indices in HCV-associated HCC, cirrhotic patients related to chronic hepatitis C infection and apparently healthy individuals in an attempt to understand some of the potential mechanisms of persistence and oncogenicity of HCV.